Cargando…

Enlarged Pericarotid Lymph Nodes Suggest Recent Ischemic Symptoms in Patients with Carotid Atherosclerosis

Atherosclerosis is a chronic inflammatory disease closely associated with immunological activity. Lymph nodes (LNs) are essential secondary lymphoid organs, in which complex immune responses occur. Enlarged LNs are commonly observed around inflamed tissues or tumors; however, their role in atheroscl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Tao, Wang, Fei, He, Yiming, Mao, Bo, Han, Mengtao, Liu, Han, Zhao, Peng, Li, Xingang, Wang, Donghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315152/
https://www.ncbi.nlm.nih.gov/pubmed/35903093
http://dx.doi.org/10.3389/fimmu.2022.900642
_version_ 1784754491734622208
author Sun, Tao
Wang, Fei
He, Yiming
Mao, Bo
Han, Mengtao
Liu, Han
Zhao, Peng
Li, Xingang
Wang, Donghai
author_facet Sun, Tao
Wang, Fei
He, Yiming
Mao, Bo
Han, Mengtao
Liu, Han
Zhao, Peng
Li, Xingang
Wang, Donghai
author_sort Sun, Tao
collection PubMed
description Atherosclerosis is a chronic inflammatory disease closely associated with immunological activity. Lymph nodes (LNs) are essential secondary lymphoid organs, in which complex immune responses occur. Enlarged LNs are commonly observed around inflamed tissues or tumors; however, their role in atherosclerosis is not well understood. We hypothesized that enlarged pericarotid LNs would be present in symptomatic patients with carotid atherosclerosis. Therefore, we recorded the size of LNs around the carotid artery during surgery in patients undergoing carotid endarterectomy (CEA) for carotid atherosclerotic stenosis. Patients were stratified by enlarged LNs, defined as a diameter ≥ 10mm in the transverse diameters. Demographic and clinical data of participants were measured and analyzed. Hematoxylin and eosin (H&E), Sirius red, DAB-enhanced Perls’ Prussian blue, alizarin red, and immunohistochemistry (IHC) staining were performed for composition identification of plaques or LNs. Symptomatic patients were defined as those presenting with an ipsilateral cerebral ischemic event. Compared with patients with non-enlarged LNs, patients with enlarged LNs were more likely to be symptomatic (22/32, 68.8% versus 9/40, 22.5%, P < 0.001) and use calcium channel blocker drugs (17/32, 53.1% versus 10/40, 25%, P=0.014). In addition, they showed lower body mass index (mean ± SD: 24.00 ± 2.66 versus 25.34 ± 2.56 kg/m(2), P=0.034), lower weight (median [interquartile range]: 64 [60.00-76.00] versus 72.5 [65.00-77.50] Kg, P = 0.046) and higher diastolic blood pressure (mean ± SD: 78.94 ± 9.30 versus 73.93 ± 8.84 mmHg, P = 0.022). The plague from patients with enlarged LNs exhibited a lower relative percentage of fibrous tissue (29.49 ± 10.73% versus 34.62 ± 10.33%, P = 0.041). The enlarged LNs remained oval-shaped by visual inspection. Compared to non-enlarged LNs, the predominant changes in enlarged LNs were atrophic lymphatic sinuses and dilated LNs parenchyma. Enlarged LNs contained more germinal centers and lymphocytes. In conclusion, symptomatic patients with carotid atherosclerosis have enlarged pericarotid LNs. The current study supports the conclusion that enlarged LNs with an activated and enhanced adaptive immune response may indicate plaque instability. Pericarotid LNs will be a promising marker of plaque stability and may be a potential therapeutic target in patients with carotid atherosclerosis.
format Online
Article
Text
id pubmed-9315152
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93151522022-07-27 Enlarged Pericarotid Lymph Nodes Suggest Recent Ischemic Symptoms in Patients with Carotid Atherosclerosis Sun, Tao Wang, Fei He, Yiming Mao, Bo Han, Mengtao Liu, Han Zhao, Peng Li, Xingang Wang, Donghai Front Immunol Immunology Atherosclerosis is a chronic inflammatory disease closely associated with immunological activity. Lymph nodes (LNs) are essential secondary lymphoid organs, in which complex immune responses occur. Enlarged LNs are commonly observed around inflamed tissues or tumors; however, their role in atherosclerosis is not well understood. We hypothesized that enlarged pericarotid LNs would be present in symptomatic patients with carotid atherosclerosis. Therefore, we recorded the size of LNs around the carotid artery during surgery in patients undergoing carotid endarterectomy (CEA) for carotid atherosclerotic stenosis. Patients were stratified by enlarged LNs, defined as a diameter ≥ 10mm in the transverse diameters. Demographic and clinical data of participants were measured and analyzed. Hematoxylin and eosin (H&E), Sirius red, DAB-enhanced Perls’ Prussian blue, alizarin red, and immunohistochemistry (IHC) staining were performed for composition identification of plaques or LNs. Symptomatic patients were defined as those presenting with an ipsilateral cerebral ischemic event. Compared with patients with non-enlarged LNs, patients with enlarged LNs were more likely to be symptomatic (22/32, 68.8% versus 9/40, 22.5%, P < 0.001) and use calcium channel blocker drugs (17/32, 53.1% versus 10/40, 25%, P=0.014). In addition, they showed lower body mass index (mean ± SD: 24.00 ± 2.66 versus 25.34 ± 2.56 kg/m(2), P=0.034), lower weight (median [interquartile range]: 64 [60.00-76.00] versus 72.5 [65.00-77.50] Kg, P = 0.046) and higher diastolic blood pressure (mean ± SD: 78.94 ± 9.30 versus 73.93 ± 8.84 mmHg, P = 0.022). The plague from patients with enlarged LNs exhibited a lower relative percentage of fibrous tissue (29.49 ± 10.73% versus 34.62 ± 10.33%, P = 0.041). The enlarged LNs remained oval-shaped by visual inspection. Compared to non-enlarged LNs, the predominant changes in enlarged LNs were atrophic lymphatic sinuses and dilated LNs parenchyma. Enlarged LNs contained more germinal centers and lymphocytes. In conclusion, symptomatic patients with carotid atherosclerosis have enlarged pericarotid LNs. The current study supports the conclusion that enlarged LNs with an activated and enhanced adaptive immune response may indicate plaque instability. Pericarotid LNs will be a promising marker of plaque stability and may be a potential therapeutic target in patients with carotid atherosclerosis. Frontiers Media S.A. 2022-07-12 /pmc/articles/PMC9315152/ /pubmed/35903093 http://dx.doi.org/10.3389/fimmu.2022.900642 Text en Copyright © 2022 Sun, Wang, He, Mao, Han, Liu, Zhao, Li and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Sun, Tao
Wang, Fei
He, Yiming
Mao, Bo
Han, Mengtao
Liu, Han
Zhao, Peng
Li, Xingang
Wang, Donghai
Enlarged Pericarotid Lymph Nodes Suggest Recent Ischemic Symptoms in Patients with Carotid Atherosclerosis
title Enlarged Pericarotid Lymph Nodes Suggest Recent Ischemic Symptoms in Patients with Carotid Atherosclerosis
title_full Enlarged Pericarotid Lymph Nodes Suggest Recent Ischemic Symptoms in Patients with Carotid Atherosclerosis
title_fullStr Enlarged Pericarotid Lymph Nodes Suggest Recent Ischemic Symptoms in Patients with Carotid Atherosclerosis
title_full_unstemmed Enlarged Pericarotid Lymph Nodes Suggest Recent Ischemic Symptoms in Patients with Carotid Atherosclerosis
title_short Enlarged Pericarotid Lymph Nodes Suggest Recent Ischemic Symptoms in Patients with Carotid Atherosclerosis
title_sort enlarged pericarotid lymph nodes suggest recent ischemic symptoms in patients with carotid atherosclerosis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315152/
https://www.ncbi.nlm.nih.gov/pubmed/35903093
http://dx.doi.org/10.3389/fimmu.2022.900642
work_keys_str_mv AT suntao enlargedpericarotidlymphnodessuggestrecentischemicsymptomsinpatientswithcarotidatherosclerosis
AT wangfei enlargedpericarotidlymphnodessuggestrecentischemicsymptomsinpatientswithcarotidatherosclerosis
AT heyiming enlargedpericarotidlymphnodessuggestrecentischemicsymptomsinpatientswithcarotidatherosclerosis
AT maobo enlargedpericarotidlymphnodessuggestrecentischemicsymptomsinpatientswithcarotidatherosclerosis
AT hanmengtao enlargedpericarotidlymphnodessuggestrecentischemicsymptomsinpatientswithcarotidatherosclerosis
AT liuhan enlargedpericarotidlymphnodessuggestrecentischemicsymptomsinpatientswithcarotidatherosclerosis
AT zhaopeng enlargedpericarotidlymphnodessuggestrecentischemicsymptomsinpatientswithcarotidatherosclerosis
AT lixingang enlargedpericarotidlymphnodessuggestrecentischemicsymptomsinpatientswithcarotidatherosclerosis
AT wangdonghai enlargedpericarotidlymphnodessuggestrecentischemicsymptomsinpatientswithcarotidatherosclerosis